We discovered that PIMREG expression was markedly increased in most cancer types, including bladder, brain and central nervous system (CNS), breast, cervical, colorectal, esophageal, gastric, head and neck, leukemia, lung, melanoma, ovarian prostate, pancreatic, prostate, sarcoma and other cancers. Here, PIMREG is linked to melanoma.